Silvia
Silvia Allegro-Baumann, Unteraegeri CH
Patent application number | Description | Published |
---|---|---|
20090123009 | METHOD FOR MANUFACTURING ACOUSTICAL DEVICES AND FOR REDUCING ESPECIALLY WIND DISTURBANCES - A method for manufacturing an acoustical device, especially a hearing device. A device casing is provided with an acoustical/electrical input converter arrangement with an electric output. An audio signal processing unit establishes audio signal processing of the device according to individual needs and/or purpose of the device. At least one electrical/mechanical output converter is provided. A filter arrangement with adjustable high-pass characteristic has a control input for the characteristic. The following operational connections are established: between the output of the input converter arrangement and the input of the filter arrangement, between the output of the filter arrangement and the control input, between said output of the filter arrangement and the input of the processing unit, between the output of the processing unit and the input of the at least once output converter. | 05-14-2009 |
Silvia Allegro-Baumann, Unterageri CH
Patent application number | Description | Published |
---|---|---|
20100092018 | METHOD FOR OPERATING A HEARING DEVICE AS WELL AS A HEARING DEVICE - In order to switch between different hearing programs to adjust to a momentary acoustic scene, a method for adjusting a hearing device, in which one of several possible hearing programs can be selected in order to adjust to a momentary acoustic scene, the method comprising the steps of detecting a desired hearing program change, changing parameters (b | 04-15-2010 |
20130108058 | BINAURAL HEARING DEVICE AND METHOD TO OPERATE THE HEARING DEVICE | 05-02-2013 |
20140105435 | METHOD FOR OPERATING A HEARING DEVICE AS WELL AS A HEARING DEVICE - A method for operating a hearing device by applying a frequency transposition scheme to an input signal of the hearing device comprising an input transducer, a signal processing unit and an output transducer, the method comprising the steps of transforming the input signal from time domain into frequency domain by applying a transformation function in order to obtain an input spectrum having a frequency range comprising a source region ( | 04-17-2014 |
Silvia Angeli, Saronno IT
Patent application number | Description | Published |
---|---|---|
20100216918 | FLAME-PROOFED THERMOPLASTIC COMPOSITIONS - Flame-proofed thermoplastic compositions include organophosphorus compounds as flame retardants; thermoplastic articles shaped therefrom do not experience deterioration of the appearance of the surfaces thereof by corrosion or deposition. | 08-26-2010 |
Silvia Araquistain, Hiawassee, GA US
Patent application number | Description | Published |
---|---|---|
20090205098 | Disposable Over-Garment - A protective over-garment is disclosed that can be manufactured entirely by making cuts in a single sheet of plastic or other flexible material. In preferred embodiments it is disposable. The sheet has a neck hole in the center and covers the user's shoulders, upper arms, back, and chest. A cut radiating from the hole allows insertion of the user's head. The rim of the hole is held against the wearer's neck by tying together two strips of material formed by cuts that partially separate them from the sheet. Similar strips can hold the first cut and/or the sides of the garment closed. In preferred embodiments the sheet can be rectangular, hourglass, or double-hourglass in shape, and/or the sheet can be folded to fit in a standard home hair coloring kit. Cuts can be perforated, and the garments can be manufactured as a continuous length of sheets joined at perforated intersections. | 08-20-2009 |
Silvia Armini, Terni IT
Patent application number | Description | Published |
---|---|---|
20100180513 | METHOD FOR IMPROVING MECHANICAL PROPERTIES OF POLYMER PARTICLES AND ITS APPLICATIONS - A method for improving the mechanical hardness of polymer particles is provided, the method comprising subjecting the polymer particles to a thermal cycle of heating and subsequently cooling. The method is applicable for use with combinations of preferably three monomers, the monomers having hydrophilic and hydrophobic groups in their polymer chain in order to achieve preferential orientation of the polymer chains in a polar solvent after applying the heating cycles of the invention (for example, but not limited to, polymethylmethacrylate and polystyrene based terpolymers and copolymers). Polymeric abrasives used in slurry compositions for polishing copper and their use in a chemical mechanical polishing method are also provided. | 07-22-2010 |
Silvia Bäck-Egli, Schachen CH
Patent application number | Description | Published |
---|---|---|
20090221967 | Intravascular Device | 09-03-2009 |
Silvia Bertinotti, Agrate Conturbia IT
Patent application number | Description | Published |
---|---|---|
20110049201 | HOSIERY DONNING DEVICE, IN PARTICULAR FOR COMPRESSION HOSIERY - A hosiery donning device, in particular for compression hosiery, has a support, a front end portion of which is inserted into the hosiery to be donned; the support defines a downwardly-facing cavity so that a foot can be inserted into the sock or stocking by making the support slide over the upper surface and instep of the foot; a handle is joined to the rear of the support, it is fixed and faces upwards in relation to the support; the cavity is defined by a saddle-shaped portion, on which at least a portion of the hosiery is gathered; the saddle-shaped portion accompanies a portion of the hosiery over the heel of the foot, when the handle is tilted forwards while the saddle-shaped portion remains in contact with the instep of the foot. | 03-03-2011 |
Silvia Bordiga, Oslo NO
Patent application number | Description | Published |
---|---|---|
20080306315 | Metal-Organic Framework Catalysts and Their Use in Hydrocarbon Transformation - The invention relates to a porous heterogeneous catalyst material comprising frameworks of inorganic cornerstones connected by organic bridges, characterized in that as organic bridges are used ligands having a complexed catalytically active metal. The metals are preferably palladium and platinum. The ligands preferably contain nitrogen donor groups for complexing the catalytically active metal and carboxylate groups connecting to the inorganic cornerstones. | 12-11-2008 |
Silvia Bradamante, Milano IT
Patent application number | Description | Published |
---|---|---|
20100203591 | Bioreactor, in particular for NMR spectroscopy - A description is given of a bioreactor ( | 08-12-2010 |
Silvia Braun, Moosburg DE
Patent application number | Description | Published |
---|---|---|
20080293874 | Polymers for the Dispersion of Pigments and Fillers - The invention relates to a polymer of the formula (I) | 11-27-2008 |
Silvia Buonamici, Boston, MA US
Patent application number | Description | Published |
---|---|---|
20100285020 | LEUKEMIC CELL CNS INFILTRATION CONTROLLED BY NOTCH-INDUCED CHEMOTAXIS - The present invention is directed to methods of preventing central nervous system leukemia, treating T-cell acute lymphoblastic leukemia, and treating immune system disorders associated with CCR7-CCL19 mediated signaling. Suitable therapeutic agents for inhibiting CCR7-CCL19 signaling and methods of identifying additional therapeutic agents useful in the methods of the present invention are also disclosed. | 11-11-2010 |
20120232087 | METHODS AND COMPOSITIONS FOR TREATING SOLID TUMORS AND OTHER MALIGNANCIES - A combination of a kinase inhibitors of mTOR and downstream effector and a hedgehog pathway inhibitor for the treatment of cancer. | 09-13-2012 |
20150025074 | METHODS AND COMPOSITIONS FOR TREATING SOLID TUMORS AND OTHER MALIGNANCIES - A combination of a kinase inhibitors of mTOR and downstream effector and a hedgehog pathway inhibitor for the treatment of cancer. | 01-22-2015 |
Silvia Cainarca, Milano IT
Patent application number | Description | Published |
---|---|---|
20090286695 | LUMINESCENT STEM CELLS AND USES THEREOF - It is described a stable recombinant stem cell able to express an apophotoprotein and produce a bioluminescent signal in the presence of a suitable chromophore as substrate in response to intracellular calcium concentration variation: methods for identifying agents modulating the differentiation of stem cells towards a specific cell lineage; methods for identifying a ligand able to stimulate a specific cell lineage target; methods for identifying an antagonist to ligand known to stimulate a specific cell lineage target uses of stable recombinant stem cells for in vitro testing of toxicity and/teratology of a substance. | 11-19-2009 |
Silvia Citelli, Stuttgart DE
Patent application number | Description | Published |
---|---|---|
20080270018 | Method for Course Prediction in Driver Assistance Systems for Motor Vehicles - In a method for course prediction in driver assistance systems for motor vehicles, a dynamic course hypothesis is created on the basis of vehicle-dynamics data of the vehicle, which method includes the following steps: | 10-30-2008 |
Silvia Colli Cantone, Torino IT
Patent application number | Description | Published |
---|---|---|
20100027561 | DYNAMIC BANDWIDTH ALLOCATION IN A PASSIVE OPTICAL ACCESS NETWORK - A method of allocating upstream bandwidth to at least a first upstream traffic flow and a second upstream traffic flow in a passive optical access network includes: a) associating a first timer to the first upstream traffic flow; and b) associating a second timer to the second upstream traffic flow. The method includes, during a given frame period: if the first timer is at its expiration value and the second timer is not at its expiration value; c) allocating a first portion of the upstream bandwidth to the first upstream traffic flow, d) verifying if a second portion of the upstream bandwidth is left after performing step c); and e) in the affirmative, allocating at least part of the second portion of the upstream bandwidth to the second upstream traffic flow before the second timer is at its expiration value, if the first timer and the second timer are not at their expiration value, f) allocating at least part of the upstream bandwidth to at least one of the first and second upstream traffic flows before respective timers are at their expiration values. | 02-04-2010 |
Silvia Colodrero, Baena ES
Patent application number | Description | Published |
---|---|---|
20110030792 | SOLAR TO ELECTRIC ENERGY CONVERSION DEVICE - The present invention features a solar-to-electric energy conversion device based on a light absorbing electrode coupled to a one-dimensional nanoparticle based photonic crystal. The function of the latter is to localize the incident light within the electrode thus enhancing the optical absorption and the power conversion efficiency of the so called dye-sensitized and organic (polymer based or hybrids) cell. The photonic crystal comprises alternating layers possessing different index of refraction and can be easily integrated into the cell. | 02-10-2011 |
Silvia Colodrero Pérez, Sevilla ES
Patent application number | Description | Published |
---|---|---|
20100178480 | MULTILAYER STRUCTURE FORMED BY NANOPARTICULAR LAMINA WITH UNIDIMENSIONAL PHOTONIC CRYSTAL PROPERTIES, METHOD FOR THE PRODUCTION THEREOF AND USE THEREOF - The subject of the present disclosure is a multilayer nanoparticular, mesoporous structure that has properties of a Bragg reflector or of a unidimensional photonic crystal in the ultraviolet, visible and infrared ranges close to the electromagnetic spectrum. The unidimensional photonic crystal is formed by laminae with different indices of refraction and of a controlled size, made up of nanoparticles, which can be deposited on different types of substrates using a simple and reliable method. The periodic alternating of laminae with different indices of refraction gives rise to a high reflection factor which can easily be observed with the naked eye and can be measured with a spectrophotometer. In contrast to other, dense, reflective structures, the mesoporous structure of this reflector allows the passage of liquids. | 07-15-2010 |
Silvia Delsanto, Torino IT
Patent application number | Description | Published |
---|---|---|
20100284593 | METHOD OF CLASSIFICATION OF TAGGED MATERIAL IN A SET OF TOMOGRAPHIC IMAGES OF COLORECTAL REGION - A method of classification of image portions corresponding to faecal residues from a tomographic image of a colorectal region, which comprises a plurality of voxels ( | 11-11-2010 |
Silvia Dewiyanti, Jurong Island SG
Patent application number | Description | Published |
---|---|---|
20100025301 | NOVEL PROCESS FOR REMOVING SULFUR FROM FUELS - A process for removing sulfur-containing compounds from fuel, said process comprising contacting the fuel in liquid phase with air to oxidize the sulfur-containing compounds, said contacting being carried out in the presence of at least one transition metal oxide catalyst, wherein the catalyst is supported on a porous support and wherein the porous support comprises a support material selected from the group consisting of a titanium oxide, a manganese oxide and a nanostructured material of the aforementioned support materials. | 02-04-2010 |
Silvia Diez-Gonzalez, Barakaldo-Vizcaya ES
Patent application number | Description | Published |
---|---|---|
20090069569 | CYCLOADDITION OF AZIDES AND ALKYNES - This invention provides a process which comprises contacting, in a reaction zone, at least one organic azide, at least one alkyne, and at least one N-heterocyclic carbene copper compound in which the ligands are either (i) a halide and an N-heterocyclic carbene or (ii) two N-heterocyclic carbenes and a BF | 03-12-2009 |
Silvia Fabiole Nicoletto, Biella IT
Patent application number | Description | Published |
---|---|---|
20110077192 | Novel Antibacterial Peptides - The present invention relates to monomeric and multimeric peptidic compounds which have antimicrobial activity, particularly against Gram-positive and Gram-negative bacteria. Further, the present invention refers to compositions comprising said peptidic compounds for medical use, for use as a disinfectant and/or detergent or for use as a preservative. | 03-31-2011 |
Silvia Fonquerna Pou, Barcelona ES
Patent application number | Description | Published |
---|---|---|
20080275038 | Imidazopyridine Derivatives as A2b Adenosine Receptor Antagonists - The present disclosure relates to imidazopyridine derivatives of formula (I): | 11-06-2008 |
20110212945 | AZABIPHENYLAMINOBENZOIC ACID DERIVATIVES AS DHODH INHIBITORS - The present disclosure relates to new azabiphenylaminobenzoic acid derivatives of formula (I); as well as processes for their preparation, pharmaceutical compositions comprising them, and their use in therapy as inhibitors of the dehydroorotate dihydrogenase (DHODH). | 09-01-2011 |
20110311485 | 1,2,4-OXADIAZOLE DERIVATIVES AND THEIR THERAPEUTIC USE - The present disclosure relates to 1, 2, 4 oxadiazole derivatives of formula (I) as well as pharmaceutical compositions comprising them, and their use in therapy as agonists of the S1P1 receptors. | 12-22-2011 |
Silvia Garcia-Vicente, Sant Feliu De Llobregat ES
Patent application number | Description | Published |
---|---|---|
20080227809 | Arylalkylamine Vanadium (V) Salts for the Treatment and/or Prevention of Diabetes Mellitus - This invention provides compounds and pharmaceutical compositions thereof for treating human type 1 and type 2 diabetes, particularly insulin-resistant diabetes. | 09-18-2008 |
20080269282 | Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof - This invention is directed to inhibitors of copper-containing amine oxidases (E.C.1.4.3.6) including semicarbazide-sensitive amine oxidase (SSAO; also known as vascular adhesion protein-1, VAP-I), and their therapeutic use in inflammatory diseases, diabetes and its associated complications, atherosclerosis, neurodegenerative diseases, obesity, hypertension and cancer. | 10-30-2008 |
20090298923 | Salicylate Conjugates Useful for Treating Metabolic Disorders - The present invention is directed to methods for treating metabolic disorders with compounds that are conjugates. The conjugates of the present invention are comprised of salicylic acid, triflusal, diflusinal, salsalate, IMD-0354, ibuprofen, diclofenac, licofelone, or HTB, and one or more antioxidants. | 12-03-2009 |
20100234452 | Anti-Inflammatory and Antioxidant Conjugates Useful for Treating Metabolic Disorders - The present invention is directed to methods for treating metabolic disorders with compounds that are conjugates. The conjugates of the present invention are comprised of salicylic acid, triflusal, diflusinal, salsalate, IMD-0354, ibuprofen, diclofenac, licofelone, or HTB, and one or more antioxidants. | 09-16-2010 |
20100239552 | Combination Therapies for Treating Metabolic Disorders - This invention is directed to pharmaceutical combinations comprising an antioxidant agent, an anti-inflammatory agent, and optionally at least one other anti-diabetic agent useful for treating metabolic disorders. This invention also encompasses pharmaceutically acceptable compositions comprising an antioxidant agent, an anti-inflammatory agent, optionally at least one other anti-diabetic agent, and at least one pharmaceutically acceptable carrier. The combinations and compositions of this invention are useful as methods for treating metabolic disorders including diabetes, particularly Type I and Type II diabetes, as well as diseases and disorders associated with diabetes, including but not limited to atherosclerosis, cardiovascular disease, inflammatory disorders, nephropathy, neuropathy, retinopathy, β-cell dysfunction, dyslipidemia, LADA, metabolic syndrome, hyperglycemia, insulin resistance, and/or chronic obstructive pulmonary disease in a mammal, particularly a diabetic mammal, and specifically a human patient. This invention is particularly directed to pharmaceutical compositions comprising an lipoic acid, one or more anti-inflammatories selected from the group consisting of diflunisal, diclofenac, dexibuprofen, dexketoprofen, naproxen, and salicylate, and optionally one or more pharmaceutically acceptable carriers. The compositions of this invention are useful as methods for treating metabolic disorders including type II diabetes, insulin resistance, beta-cell dysfunction, and hyperglycemia in a patient, particularly a diabetic patient. | 09-23-2010 |
20120149769 | Thiocarbonates as Anti-Inflammatory and Antioxidant Compounds Useful For Treating Metabolic Disorders - The invention is directed to thiocarbonate compounds of Formula (I)-(III) and methods of treating atherosclerosis, neuropathy, nephropathy, retinopathy, inflammatory disorders, COPD, cardiovascular diseases, metabolic disorders, type I diabetes mellitus, type II diabetes mellitus, LADA, Wolfram Syndrome 1, Wolcott-Rallison syndrome, metabolic syndrome, dyslipidemia, hyperglycemia, or insulin resistance. The compounds of the invention are also useful for protecting pancreatic beta-cells and for reducing free fatty acids, triglycerides, advanced glycated end products, ROS, lipid peroxidation, tissue and plasma TNFalpha and IL6 levels, or for delaying or preventing cardiovascular complications associated with atherosclerosis. | 06-14-2012 |
20130267726 | Thiocarbonates as Anti-Inflammatory and Antioxidant Compounds Useful For Treating Metabolic Disorders - The invention is directed to thiocarbonate compounds of Formula (I)-(III) and methods of treating atherosclerosis, neuropathy, nephropathy, retinopathy, inflammatory disorders, COPD, cardiovascular diseases, metabolic disorders, type I diabetes mellitus, type II diabetes mellitus, LADA, Wolfram Syndrome 1, Wolcott-Rallison syndrome, metabolic syndrome, dyslipidemia, hyperglycemia, or insulin resistance. The compounds of the invention are also useful for protecting pancreatic beta-cells and for reducing free fatty acids, triglycerides, advanced glycated end products, ROS, lipid peroxidation, tissue and plasma TNFalpha and IL6 levels, or for delaying or preventing cardiovascular complications associated with atherosclerosis. | 10-10-2013 |
20130281413 | Salicylate Conjugates Useful For Treating Metabolic Disorders - The present invention is directed to methods for treating metabolic disorders with compounds that are conjugates. The conjugates of the present invention are comprised of salicylic acid, triflusal, diflusinal, salsalate, IMD-0354, ibuprofen, diclofenac, licofelone, or HTB, and one or more antioxidants. | 10-24-2013 |
20130281520 | Anti-Inflammatory And Antioxidant Conjugates Useful For Treating Metabolic Disorders - The present invention is directed to methods for treating metabolic disorders with compounds that are conjugates. The conjugates of the present invention are comprised of salicylic acid, triflusal, diflusinal, salsalate, IMD-0354, ibuprofen, diclofenac, licofelone, or HTB, and one or more antioxidants. | 10-24-2013 |
20140357602 | Combination Therapies For Treating Metabolic Disorders - This invention is directed to pharmaceutical combinations comprising an antioxidant agent, an anti-inflammatory agent, and optionally at least one other anti-diabetic agent useful for treating metabolic disorders. This invention also encompasses pharmaceutically acceptable compositions comprising an antioxidant agent, an anti-inflammatory agent, optionally at least one other anti-diabetic agent, and at least one pharmaceutically acceptable carrier. The combinations and compositions of this invention are useful as methods for treating metabolic disorders including diabetes, particularly Type I and Type II diabetes, as well as diseases and disorders associated with diabetes, including but not limited to atherosclerosis, cardiovascular disease, inflammatory disorders, nephropathy, neuropathy, retinopathy, β-cell dysfunction, dyslipidemia, LADA, metabolic syndrome, hyperglycemia, insulin resistance, and/or chronic obstructive pulmonary disease in a mammal, particularly a diabetic mammal, and specifically a human patient. This invention is particularly directed to pharmaceutical compositions comprising an lipoic acid, one or more anti-inflammatories selected from the group consisting of diflunisal, diclofenac, dexibuprofen, dexketoprofen, naproxen, and salicylate, and optionally one or more pharmaceutically acceptable carriers. The compositions of this invention are useful as methods for treating metabolic disorders including type II diabetes, insulin resistance, beta-cell dysfunction, and hyperglycemia in a patient, particularly a diabetic patient. | 12-04-2014 |
20150025006 | Pharmaceutical Combinations Including Anti-Inflammatory and Antioxidant Conjugates Useful for Treating Metabolic Disorders - One aspect of the present invention is a pharmaceutical combination comprising (a) an anti-inflammatory agent/anti-oxidant agent conjugate; and (b) an insulin secretogogue, an insulin sensitizer, an alpha-glucosidase inhibitor, a peptide analog, or a combination thereof. Another aspect of the invention relates to methods of treating metabolic disorders with such conjugates. | 01-22-2015 |
Silvia Gatti Mcarthur, Basel CH
Patent application number | Description | Published |
---|---|---|
20080261957 | DIHYDRO-BENZO[B][1,4]DIAZEPIN-2-ONE SULFONAMIDE DERIVATIVES - The present invention relates to compounds of formula (I), a process for the manufacture thereof, their use for the preparation of medicaments for treating CNS disorders and pharmaceutical compositions containing them. Compounds of formula (I) are represented by general formula (I) | 10-23-2008 |
20080280924 | PYRIDINE AND PYRIMIDINE DERIVATIVES AS MGLUR2 ANTAGONISTS - The present invention relates to compounds of formula (I) | 11-13-2008 |
20080300250 | ACETYLENYL-PYRAZOLO-PYRIMIDINE DERIVATIVES - The present invention relates to compounds of formula (I): | 12-04-2008 |
20090143580 | SUBSTITUTED PYRAZOLO [1,5-a] PYRIMIDINES AS METABOTROPIC GLUTAMATE ANTAGONISTS - The present invention relates to compounds of formula (I) | 06-04-2009 |
20090318474 | PYRIDINE AND PYRIMIDINE DERIVATIVES AS MGLUR 2 ANTAGONISTS - The present invention relates to compounds of formula (I), a process for the manufacture thereof, pharmaceutical compositions containing them, and their use for treating CNS disorders: | 12-24-2009 |
20100210642 | ACETYLENYL-PYRAZOLO-PYRIMIDINE DERIVATIVES - The present invention relates to compounds of formula (I): | 08-19-2010 |
20110263615 | PYRIDINE AND PYRIMIDINE DERIVATIVES AS MGLUR2 ANTAGONISTS - The present invention relates to compounds of formula (I) | 10-27-2011 |
20120041002 | SUBSTITUTED PYRAZOLO [1,5-A] PYRIMIDINES AS METABOTROPIC GLUTAMATE ANTAGONISTS - The present invention relates to compounds of formula (I) | 02-16-2012 |
Silvia Geron, Ramat-Efal IL
Patent application number | Description | Published |
---|---|---|
20110014583 | ORTHODONTIC BRACKET AND METHOD - Various designs of dental orthodontic brackets are described. Some brackets are self-ligating with no moving parts. Some brackets include multiple pathways for wires so an amount and type of force applied by the bracket can be varied without moving the bracket. Optionally, a same bracket is used for an entire orthodontic process. | 01-20-2011 |
Silvia Golsch, Wurselen DE
Patent application number | Description | Published |
---|---|---|
20090078949 | LIGHT EMITTING DEVICE WITH CONVERSION STRUCTURE - The invention relates to a light-emitting device comprising a conversion structure and one or several LEDs ( | 03-26-2009 |
20100127286 | ILLUMINATION SYSTEM COMPRISING A GREEN-EMITTING CERAMIC LUMINESCENCE CONVERTER - An Illumination system comprising a radiation source and a monolithic ceramic luminescence converter comprising at least one phosphor capable of absorbing a part of the light emitted by the radiation source and emitting light of a wavelength different from that of the absorbed light, wherein said at least one phosphor is an europium(II)-activated oxonitridosilicate of the general formula (Sr1-a-b-c-d-e-fCabBacMgdZneCef)Six-gGegNyOz:Eua, wherein 0.001 | 05-27-2010 |
Silvia Gómez Sebastián, Madrid ES
Patent application number | Description | Published |
---|---|---|
20100330068 | MONOMERIC VHH DOMAIN DERIVED FROM ANTI-VP6 CAMELID ANTIBODIES, DIMERIC DOMAIN, IMMUNISATION METHOD, ROTAVIRUS DETECTION METHOD, COMPOSITION, PREVENTION AND TREATMENT METHODS FOR ROTAVIRUS INFECTIONS - Monomeric VHH domain derived from anti-VP6 camelid antibodies, dimeric domain, immunisation method, rotavirus detection method, vaccine composition, prevention and treatment methods for rotavirus infections, wherein said domain may be any of the amino acid sequences shown in SEQ ID No. 1, SEQ ID No. 2, SEQ ID No. 3 or SEQ ID No. 4, and wherein said domains bind to protein VP6 of Group A rotavirus. | 12-30-2010 |
20140178405 | MONOMERIC VHH DOMAIN DERIVED FROM ANTI-VP6 CAMELID ANTIBODIES, DIMERIC DOMAIN, IMMUNISATION METHOD, ROTAVIRUS DETECTION METHOD, COMPOSITION, PREVENTION AND TREATMENT METHODS FOR ROTAVIRUS INFECTIONS - Monomeric VHH domain derived from anti-VP6 camelid antibodies, dimeric domain, immunisation method, rotavirus detection method, vaccine composition, prevention and treatment methods for rotavirus infections, wherein said domain may be any of the amino acid sequences shown in SEQ ID No. 1, SEQ ID No. 2, SEQ ID No. 3 or SEQ ID No. 4, and wherein said domains bind to protein VP6 of Group A rotavirus. | 06-26-2014 |
Silvia Gual Roig, Barcelona ES
Patent application number | Description | Published |
---|---|---|
20100168161 | DERIVATIVES OF 4-(2-AMINO-1-HYDROXYETHYL)PHENOL AS AGONISTS OF THE BETA2 ADRENERGIC RECEPTOR - The present relates to compounds of formula (I): | 07-01-2010 |
20140303127 | NEW CYCLOHEXYLAMINE DERIVATIVES HAVING BETA 2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITIES - The present invention relates to novel compounds having β2 adrenergic agonist and M3 muscarinic antagonist dual activity, to pharmaceutical compositions containing them, to the process for their preparation and to their use in respiratory therapies. | 10-09-2014 |
20140378421 | NEW CYCLOHEXYLAMINE DERIVATIVES HAVING beta2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITIES - The present invention relates to novel compounds having β2 adrenergic agonist and M3 muscarinic antagonist dual activity, to pharmaceutical compositions containing them, to the process for their preparation and to their use in respiratory therapies. | 12-25-2014 |
Silvia Gual Roig, Cabrera De Mar ES
Patent application number | Description | Published |
---|---|---|
20090042933 | Derivatives of 4-(2-amino -1-hydroxyethyl)phenol as agonists of the Beta2 adrenergic receptor - A compound of formula (I) or a pharmaceutically-acceptable salt, solvate or stereoisomer thereof wherein R | 02-12-2009 |
20110251165 | DERIVATIVES OF 4-(2-AMINO-1-HYDROXYETHYL)PHENOL AS AGONISTS OF THE BETA2 ADRENERGIC RECEPTOR - The present invention provides a compound of formula (I) wherein: R | 10-13-2011 |
20110251166 | DERIVATIVES OF 4-(2-AMINO-1-HYDROXYETHYL)PHENOL AS AGONISTS OF THE BETA2 ADRENERGIC RECEPTOR - The present invention provides a compound of formula (I) wherein: R | 10-13-2011 |
Silvia Hangl, Nurnberg DE
Patent application number | Description | Published |
---|---|---|
20100244654 | Built-In Lamp with Cable, in Particular for Aerodrome Lighting - A lamp which has a lamp glass envelope ( | 09-30-2010 |
Silvia Heuerding, Basel CH
Patent application number | Description | Published |
---|---|---|
20090203777 | ORGANIC COMPOUNDS - The invention describes novel pharmaceutically acceptable salt forms of camostat, processes for lyophilisation, taste-masked formulations, nebulised formulations and the use of each of the fore-going in the treatment of respiratory diseases, particularly cystic fibrosis and chronic obstructive pulmonary disease (COPD). | 08-13-2009 |
20100221331 | PHARMACEUTICAL COMPOSITIONS COMPRISING COLLOIDAL SILICON DIOXIDE - The present invention provides a pharmaceutical composition comprising a macrolide solid dispersion, a disintegrant and colloidal silicon dioxide. The composition comprises 1 to 5% colloidal silicon dioxide by weight. | 09-02-2010 |
20110306630 | PHARMACEUTICAL COMPOSITIONS COMPRISING COLLOIDAL SILICON DIOXIDE - A pharmaceutical composition comprising a macrolide solid dispersion, a disintegrant and colloidal silicon dioxide, wherein the composition comprises 1 to 5% colloidal silicon dioxide by weight. | 12-15-2011 |
20120208882 | Organic Compounds - The invention describes novel pharmaceutically acceptable salt forms of camostat, processes for lyophilisation, taste-masked formulations, nebulised formulations and the use of each of the fore-going in the treatment of respiratory diseases, particularly cystic fibrosis and chronic obstructive pulmonary disease (COPD). | 08-16-2012 |
20120289536 | Pharmaceutical Compositions Comprising Colloidal Silicon Dioxide - A pharmaceutical composition comprising a macrolide solid dispersion, a disintegrant and colloidal silicon dioxide, wherein the composition comprises 1 to 5% colloidal silicon dioxide by weight. | 11-15-2012 |
Silvia Hohagen, Wuppertal DE
Patent application number | Description | Published |
---|---|---|
20080302448 | WET ON WET METHOD AND CHROME-FREE ACIDIC SOLUTION FOR THE CORROSION CONTROL TREATMENT OF STEEL SURFACES - A process for anticorrosion treatment of bare metal surfaces comprising steel surfaces, wherein the bare metal surfaces are contacted with an acidic aqueous solution of a fluoro complex of at least one element M selected from the group B, Si, Ti, Zr and Hf, at least one further component which is selected from among: a buffer system for the pH range from 2.5 to 5.5, nitrate ions, copper ions, silver ions, vanadium or vanadate ions, bismuth ions, magnesium ions, zinc ions, manganese ions, cobalt ions, nickel ions, tin ions, aromatic carboxylic acids with at least two groups containing donor atoms, or derivatives of such carboxylic acids, and silica particles with an average particle size of below 1 μm; and contains no more than 1 mg/l of an organic polymer with allylamine or vinylamine monomers; the metal surfaces are then rinsed with water and thereafter are coated with a cathodically depositable electro-dipcoating. | 12-11-2008 |
Silvia Jung-Rossetti, Munich DE
Patent application number | Description | Published |
---|---|---|
20100063187 | COMPOSITIONS CONTAINING PHOSPHONATE-FUNCTIONAL PARTICLES - Phosphonatoalkylsilyl-functional particles have high stability and resistance to agglomeration. When used in curable binder compositions, the particles contribute to a high level of scratch resistance. | 03-11-2010 |
20130130041 | SELF-ADHESIVE SILICONE ELASTOMERS - Composite materials contain a silicone addition crosslinkable silicone elastomer composition comprising an organopolysiloxane having aliphatic unsaturation, an Si—H functional cyclic organopolysiloxane, a hydrosilylation catalyst, together with specific adhesion promoters, applied to a substrate material. | 05-23-2013 |
Silvia Karthauser, Koln DE
Patent application number | Description | Published |
---|---|---|
20080220229 | Method for Structured Application of Molecules to a Strip Conductor and Molecular Memory Matrix - The invention relates to a method for a structured application of molecules on a strip conductor and to a molecular memory matrix. The inventive method makes it possible, for the first time, to economically and simply apply any number of molecular memory elements on the strip conductor in a structured and targeted way, thereby making available, also for the first time, a memory matrix at a molecular level. | 09-11-2008 |
Silvia Koch, Albstadt DE
Patent application number | Description | Published |
---|---|---|
20100320146 | HYDROPHILIC MEMBRANES WITH A NON-IONIC SURFACTANT - The invention relates to hydrophilic membranes which are supplemented or treated with a non-ionic surfactant and processes for preparing such membranes. The membranes are particularly suitable for plasma separation or for haemodialysis and haemodiafiltration, but can also advantageously be used in other applications. Accordingly, the invention is further directed to the use of such membranes for plasma separation, plasma filtration, micro filtration, plasma therapy, haemodialysis and haemodiafiltration or cell filtration applications, respectively. The treated hydrophilic membranes show excellent biocompatibility, such as reduced platelet drop and decreased TAT levels. | 12-23-2010 |
Silvia Krömer, Pollhagen DE
Patent application number | Description | Published |
---|---|---|
20100176647 | Slide Fastener Element, Cushion Arrangement and Vehicle Seat - A slide fastener element, cushion arrangement, vehicle seat or interior covering part. The slide fastener element includes a flexible, foamable lattice that is provided with a plurality of holes, and a plurality of slide fastener teeth secured directly to the lattice. | 07-15-2010 |
Silvia Lapenna, Livorno IT
Patent application number | Description | Published |
---|---|---|
20090298175 | Steroidal Ligands and Their Use in Gene Switch Modulation - The present invention relates to steroidal ligands for use in nuclear receptor-based inducible gene expression systems. The invention further relates to methods of modulating the expression of genes of interest with a system containing one or more nuclear receptor complexes and one or more steroidal ligands. Further aspects include ligand compositions including therapeutic compositions. | 12-03-2009 |
20140057349 | Steroidal Ligands and Their Use in Gene Switch Modulation - The present invention relates to steroidal ligands for use in nuclear receptor-based inducible gene expression systems. The invention further relates to methods of modulating the expression of genes of interest with a system containing one or more nuclear receptor complexes and one or more steroidal ligands. Further aspects include ligand compositions including therapeutic compositions. | 02-27-2014 |
Silvia Lazcano Urena, Madrid ES
Patent application number | Description | Published |
---|---|---|
20090241682 | Device for fixing of a prismatic mechanical test piece, method of utilization thereof and uses - A device for the fixing of a prismatic mechanical test piece, which consists of two mechanisms that secure the test piece ( | 10-01-2009 |
Silvia Martin-Puig, Cambridge, MA US
Patent application number | Description | Published |
---|---|---|
20110033430 | METHODS FOR THE INDUCTION OF A CELL TO ENTER THE ISLET 1+ LINEAGE AND A METHOD FOR THE EXPANSION THEREOF - The present invention relates to methods for the induction and a cell to enter the Islet 1 | 02-10-2011 |
Silvia Martinucci, Verona IT
Patent application number | Description | Published |
---|---|---|
20080249132 | Piperidine Carboxyamide Derivate Suitable as Tachykinin Receptor Antagonist - The present invention relates to the compound of formula (I) | 10-09-2008 |
Silvia Mcmanus-Munoz, Castro Valley, CA US
Patent application number | Description | Published |
---|---|---|
20100311085 | CELL ASSAY KIT AND METHOD - A method and kit for assaying a cell sample for the presence of at least a threshold number of cells of a given type are disclosed. The kit includes an assay device having a sample chamber for receiving the cell sample and an elongate collection chamber containing a selected-density and/or viscosity medium and having along its length, a plurality of cell-collection regions, and particles which are capable of specific attachment to cells of the selected cell type, and which are effective, when attached to the cells, to increase the density or magnetic susceptibility of the cells. In operation, particle-bound cells and particles in the cell sample are drawn through the elongate collection chamber under the influence of a gravitational or selected centrifugal or magnetic-field force until the particle-bound cells and particles completely fill successive cell-collection regions in the collection chamber. Indicia associated with at least one collection regions indicates a concentration of cells of the selected type effective to at least partially fill that collection region. | 12-09-2010 |
20110207150 | CELL ASSAY KIT AND METHOD - A method and kit for assaying a cell sample for the presence of at least a threshold number of cells of a given type are disclosed. The kit includes an assay device having a sample chamber for receiving the cell sample and an elongate collection chamber containing a selected-density and/or viscosity medium and having along its length, a plurality of cell-collection regions, and particles which are capable of specific attachment to cells of the selected cell type, and which are effective, when attached to the cells, to increase the density or magnetic susceptibility of the cells. In operation, particle-bound cells and particles in the cell sample are drawn through the elongate collection chamber under the influence of a gravitational or selected centrifugal or magnetic-field force until the particle-bound cells and particles completely fill successive cell-collection regions in the collection chamber. Indicia associated with at least one collection regions indicates a concentration of cells of the selected type effective to at least partially fill that collection region. | 08-25-2011 |
Silvia Merlini, Milano IT
Patent application number | Description | Published |
---|---|---|
20100099812 | METHOD FOR PREPARING A HYDROGEL THROUGH THE USE OF ALKOXYDES, THE PRODUCT THUS OBTAINED AND THE USE THEREOF - The present invention relates to a process for the preparation of a completely biocompatible and reab-sorbable hydrogel, through the use of alcoxides of polymers and/or resins containing hydroxyl functions. The invention also relates to the hydrogel obtainable with said method and uses thereof. In particular, the invention relates to the use of said hydrogel for the preparation of an injectable filler for correcting and/or treating different types of tissue deficits. | 04-22-2010 |
Silvia Miramanda, Barcelona ES
Patent application number | Description | Published |
---|---|---|
20090128593 | PRINTERS AND PRINTHEAD CLEANING PRIMARILY IN PAGE-WIDE ARRAY PRINTERS - A method of printing on a substrate and a printer are provided. The method uses a printer comprising a print head and a mask having a hole therethrough, the mask being disposed between the print head and the substrate, and comprises aligning the hole with the print head; printing on the substrate through the hole; and misaligning the hole with the print head so that the print head is covered by the mask. The method may allow the servicing of a print head in the array while the printer is printing on the substrate using at least one of the remainder of the print heads in the array. | 05-21-2009 |
20090128594 | DEFECTIVE NOZZLE REPLACEMENT IN A PRINTER - Printing is performed at a full resolution using a first set of nozzles and a second set of nozzles arranged on a printhead. Printing is performed at less than the full resolution using the first set of nozzles less any nozzles in the first set of nozzles that have been determined to be defective. T he second set of nozzles is not used for printing at less than the full resolution except for a subset of nozzles in the second set of nozzles that are used to replace nozzles from the first set of nozzles that have been determined to be defective. | 05-21-2009 |
20090237443 | PRINT HEAD SERVICING FOR A PAGE WIDE ARRAY PRINTER - A page wide array printer comprises a print head bar which carries an array of print nozzles, and which is static during a printing operation. A carriage has print head service elements. The print head bar is movable perpendicularly to the plane of the print medium beneath the print head, between a lowered print position and a raised service position. The carriage is moveable along the print head to perform a service operation when the print head is in the raised position. | 09-24-2009 |
20100277525 | METHOD OF PRINTING AND PRINTER - A method of printing on a substrate in a page-wide array printer comprises printing on the substrate as the substrate is moved through a printing zone of the printer in a first direction, and printing on the substrate as the substrate is moved through the printing zone in a second direction different to the first direction. | 11-04-2010 |
Silvia Muro-Galindo, Silver Spring, MD US
Patent application number | Description | Published |
---|---|---|
20100151005 | TARGETED CARRIERS FOR INTRACELLULAR DRUG DELIVERY - The invention provides a method for delivering a cargo molecule into a cell using a targeted DNA-based carrier (e.g., DNA dendrimer). Compositions and kits useful in the practice of the methods are also provided. | 06-17-2010 |
20120076730 | PEPTIDES FOR TRANSPORT OF THERAPEUTICS AND THEIR CARRIERS IN MOUSE MODELS AND HUMANS - A system for targeted delivery of agents (e.g., molecular probes, diagnostic agents, therapeutic agents, imaging agents, research or analytical compounds, enzymes, peptides, proteins, lipids, lipoproteins, sugars, hormones, vitamins, nucleic acids, viruses, bacteria, and/or cells) including use of a composition containing the agent and a targeting moiety, specific for a determinant at the target location. An exemplary composition of the system includes a targeting moiety of one of peptides γ3, 2γ3, 3γ3, A1, B7, B8, B9, B1O, and D6, specific for targeting ICAM-I. The system enables effective, versatile, and safe targeting and transport of agents. The system is useful in research applications, as well as in the context of translational science and clinical interventions. | 03-29-2012 |
20120263652 | TARGETED CARRIERS FOR DRUG DELIVERY ACROSS THE GASTROINTESTINAL EPITHELIUM - A system and method for transcellular transport of compositions containing agents (e.g., research, analytical, reporter or molecular probes, diagnostic and therapeutic agents, biologically active agents, research agents, analytical agents, imaging agents, monitoring agents, enzymes, proteins, peptides, nucleic acids, lipids, sugars, hormones, lipoproteins, chemicals, viruses, bacteria, cells, including modified cells, biosensors, markers, antibodies and/or ligands) across the gastrointestinal epithelial layer including use of a composition containing the agent and a targeting moiety, specific for a determinant at the target location. An exemplary composition of the system includes an anti-ICAM antibody targeting moiety, specific for targeting ICAM-1. The system enables effective, versatile, and safe targeting and transport of agents. The system is useful in research applications, as well as in the context of translational science and clinical interventions. | 10-18-2012 |
20130004490 | DELIVERY OF TRANSTHYRETIN ACROSS THE BLOOD-BRAIN BARRIER AS A TREATMENT FOR ALZHEIMER'S DISEASE - The invention provides a composition comprising transthyretin and an ICAM-1 targeting agent, wherein the transthyretin and ICAM-1 targeting agent are coupled together, as well as methods of preparing such compositions. The invention further provides a diabody capable of binding specifically to ICAM-1 and transthyretin. The invention also provides a method of use of such composition in the manufacture of a medicament for treating an amyloid-β related neurodegenerative disease, comprising administering to a subject a composition comprising transthyretin coupled to an ICAM-1 targeting agent in an amount effective to treat the neurodegenerative disease, wherein the composition is administered to the subject outside of the blood-brain barrier. | 01-03-2013 |
20130095091 | METHODS OF REGULATING UPTAKE AND TRANSCELLULAR TRANSPORT OF LEUKOCYTES AND THERAPEUTICS - Methods for controlling and regulating engulfment, uptake and/or transcellular transport at a stage following initial engagement of an agent to the endothelium are provided, based on the identification of CAM-mediated endocytosis and the sphingomyelin/ceramide pathway as active steps in transcellular TEM. Administration of regulators relating to the identified pathways, such as NHE1, sphingomyelinases, acid sphingomyelinase and ceramide, permit control and regulation of uptake and transcellular transport. Control and regulation of uptake and/or transcellular transport is applicable in strategies to modulate inflammation, provide controlled and/or targeted delivery of agents, control pathogenic invasion, recover action of an inhibited CAM-mediated uptake or transendothelial pathway, or provide uptake or transendothelial transport by targeting cell surface markers other than ICAM-1. | 04-18-2013 |
20140314666 | TARGETED CARRIERS FOR DRUG DELIVERY ACROSS THE GASTROINTESTINAL EPITHELIUM - A system and method for transcellular transport of compositions containing agents (e.g., research, analytical, reporter or molecular probes, diagnostic and therapeutic agents, biologically active agents, research agents, analytical agents, imaging agents, monitoring agents, enzymes, proteins, peptides, nucleic acids, lipids, sugars, hormones, lipoproteins, chemicals, viruses, bacteria, cells, including modified cells, biosensors, markers, antibodies and/or ligands) across the gastrointestinal epithelial layer including use of a composition containing the agent and a targeting moiety, specific for a determinant at the target location. An exemplary composition of the system includes an anti-ICAM antibody targeting moiety, specific for targeting ICAM-1. The system enables effective, versatile, and safe targeting and transport of agents. The system is useful in research applications, as well as in the context of translational science and clinical interventions. | 10-23-2014 |
Silvia Murra Rischmagui, El Paso, TX US
Patent application number | Description | Published |
---|---|---|
20080249831 | Business method and system for sponsoring a special event - A business method and system centered on an enabling facility for providing special events includes a central area for observation of the special event by the sponsors of the special event or by those accompanying the attendees to the special event and a plurality of special activity areas. A staff at the enabling facility will introduce and guide the attendees to the selected activities. Also included in the enabling facility is a security system for the special event. | 10-09-2008 |
Silvia Orlanducci, Roma IT
Patent application number | Description | Published |
---|---|---|
20100072878 | HIGH FREQUENCY, COLD CATHODE, TRIODE-TYPE, FIELD-EMITTER VACUUM TUBE AND PROCESS FOR MANUFACTURING THE SAME - Disclosed herein is a high frequency, cold cathode, triode-type, field-emitter vacuum tube including a cathode structure, an anode structure spaced from the cathode structure, and a control grid, wherein the cathode structure and the anode structure are formed separately and bonded together with the interposition of spacers, and the control grid is integrated in the anode structure. | 03-25-2010 |
Silvia Ortega Gutiérrez, Madrid ES
Patent application number | Description | Published |
---|---|---|
20100190856 | Novel Polyhydroxylated Compounds as Fatty Acid Synthase (FASN) Inhibitors - The present invention relates to new polyhydroxylated compounds and, in particular, to its activity as fatty acid synthase (FASN) inhibitors and to their use for the treatment of pathological states for which an inhibitor of this enzyme is indicated. The invention further relate to pharmaceutical compositions containing them and to a process for the preparation of such compounds. | 07-29-2010 |
Silvia Paddock, Solna SE
Patent application number | Description | Published |
---|---|---|
20080233657 | METHODS TO PREDICT THE OUTCOME OF TREATMENT WITH ANTIDEPRESSANT MEDICATION - The invention provides a method for determining the outcome of treatment with an antidepressant medication in a patient. In particular, the invention provides a method of screening patients to identify those patients with a decreased risk of non-response to treatment with antidepressant medication comprising: (a) obtaining a sample of genetic material from the patients, and (b) assaying the sample for the presence of a genotype in the patients which is associated with a decreased risk of non-response to treatment with antidepressant medication, wherein the genotype is characterized by a polymorphism in a HTR2A, GRIK4, BCL2, or a combination thereof. | 09-25-2008 |
20110118133 | METHODS TO IDENTIFY PATIENTS AT RISK OF DEVELOPING ADVERSE EVENTS DURING TREATMENT WITH ANTIDEPRESSANT MEDICATION - The invention provides a method of screening patients to identify those patients more likely to exhibit an increased risk of treatment-emergent suicidal ideation comprising: (a) obtaining a sample of genetic material from the patients, and (b) assaying the sample for the presence of a genotype in the patients which is associated with an increased risk of treatment-emergent suicidal ideation, wherein the genotype is characterized by a polymorphism in a gene selected from the group consisting of glutamine receptor, ionotropic, kainate 2 (GRIK2); glutamate receptor ionotropic AMPA 3 (GRIA3); and combinations thereof. | 05-19-2011 |
Silvia Panzavolta, Forli' IT
Patent application number | Description | Published |
---|---|---|
20100183569 | POROUS COMPOSITE MATERIAL, PREPARATION PROCESS THEREOF AND USE TO REALIZE TISSUE ENGINEERING DEVICES - The present invention refers to a porous composite material, wherein at least one interdispersed biopolymer is present, with a calcium-phosphate mineral component comprising from 50 w/% to 95 w/% of α-tricalcium phosphate (α-TCP, α-Ca | 07-22-2010 |
Silvia Passos Andrade, Belo Horizonte BR
Patent application number | Description | Published |
---|---|---|
20100249238 | PHARMACEUTICAL COMPOSITIONS COMPRISING SEMICARBAZONES AND THIOSEMICARBAZONES AND METHOD FOR TREATING INFLAMMATORY, PAINFUL AND FEBRILE CONDITIONS AND PREVENTING SIGNS AND SYMPTOMS OF INFLAMMATION - The present patent application refers to pharmaceutical compositions comprising at least a semicarbazone or a thiosemicarbazone, or a pharmaceutically acceptable salt, hydrated or solvated thereof, for the treatment of inflammatory, febrile and painful inflammatory conditions, inflammatory edema and peripheral or central neurophatic painful conditions or prevention of signs and symptoms of inflammation. Claim also pharmaceutical compositions comprising at least a semicarbazone, or a thiosemicarbazone, or a pharmaceutically acceptable salt, hydrated or solvated thereof and a therapeutically effective amount of these compounds, mixed or included in a pharmaceutically acceptable carrier or excipient or a thiosemicarbazone is provided as sustained or controlled release systems for human and veterinary use in solutions or in the solid state. | 09-30-2010 |
Silvia Pastorekova, Stupava SK
Patent application number | Description | Published |
---|---|---|
20090176240 | MN/CA IX and Cancer Prognosis - Herein disclosed are methods that are prognostic for neoplastic/preneoplastic disease in a subject vertebrate, wherein said disease is associated with a tissue that normally expresses MN, but which MN expression is lost or diminished upon carcinogenesis. Exemplary of the types of preneoplastic/neoplastic diseases subject to the prognostic methods of this invention are those of gastric mucosa, gallbladder, biliary ducts, and ductal cells of duodenal glands. An exemplary prognostic method comprises comparing the level of MN gene expression product in a tissue sample from the affected subject, with the average MN gene expression product level found in analogous preneoplastic/neoplastic tissue samples; an above average MN gene expression product level indicates poorer prognosis for the subject. MN gene expression products useful in the prognostic methods include MN protein, MN polypeptide, and/or MN nucleic acids. | 07-09-2009 |
20100267040 | MN/CA IX and Cancer Prognosis - Herein disclosed are methods that are prognostic for neoplastic/preneoplastic disease in a subject vertebrate, wherein said disease is associated with a tissue that normally expresses MN, but which MN expression is lost or diminished upon carcinogenesis. Exemplary of the types of preneoplastic/neoplastic diseases subject to the prognostic methods of this invention are those of gastric mucosa, gallbladder, biliary ducts, and ductal cells of duodenal glands. An exemplary prognostic method comprises comparing the level of MN gene expression product in a tissue sample from the affected subject, with the average MN gene expression product level found in analogous preneoplastic/neoplastic tissue samples; an above average MN gene expression product level indicates poorer prognosis for the subject. MN gene expression products useful in the prognostic methods include MN protein, MN polypeptide, and/or MN nucleic acids. | 10-21-2010 |
Silvia Pato, Lisbon PT
Patent application number | Description | Published |
---|---|---|
20110069955 | FAILSAFE OPTICAL SPLITTER AND METHOD TO ISOLATE FAULTS IN A PASSIVE OPTICAL NETWORK - An optical splitter for a passive optical network for telecommunication signal transmission with an optical line terminal includes a wavelength selective optical electrical converter, an AC/DC splitter, an energy reservoir and optical switches, where the splitter comprises also a data transmission processing module by which the optical switches can be controlled according to data signals transmitted from the optical line terminal. | 03-24-2011 |
Silvia Peris Miras, Sant Joan Despí (barcelona) ES
Patent application number | Description | Published |
---|---|---|
20110086016 | Enzymatic pre-mixture against Gram negative bacteria colonization in the animal intestinal tract - The invention provides pre-mixture for animal feeding comprising: (a) a polymer or a mixture of polymers, with a content in mannose comprised between 10% and 100%; (b) β-mannanase enzyme; and (c) an anti-binding agent; wherein the anti-binding agent has an absorptive capacity higher than 20%, and a bulk density which is comprised between 0.10 and 2.70 g/cm | 04-14-2011 |
Silvia Petricci, Bresso IT
Patent application number | Description | Published |
---|---|---|
20090008596 | HEAT TRANSFER FLUIDS - Use as heat transfer fluids in the presence of metals and/or Lewis acids of mixtures comprising: (A) hydrofluoroethers and/or hydrofluoropolyethers, liquid under the environmental conditions (25° C., 1 atm); (B) a compound having a fluoropolyether structure having end groups selected from the pyridine, amine, aryl classes; and having a number average molecular weight comprised between 400 and 10,000. | 01-08-2009 |
20110230631 | Polyfunctional (per)fluoropolyethers - The invention pertains to novel (per)fluoropolyethers comprising at least one (per)fluoropolyoxyalkylene chain (chain R | 09-22-2011 |
20130310246 | Liquid compositions of fluorinated anion exchange polymers - A liquid composition comprising: | 11-21-2013 |
Silvia Piuri, Saronno IT
Patent application number | Description | Published |
---|---|---|
20080207575 | Process For The Preparation Of Drospirenone - A process is described for the preparation of drospirenone, a synthetic steroid with progestogenic, antimineralocorticoid and antiandrogenic activity, useful for preparing pharmaceutical compositions with contraceptive action; comprising the oxidation of 17α-(3-hydroxypropyl)-6β,7β,15β,16β-dimethylene-5β-androstane-3β,5,17β-triol. | 08-28-2008 |
20100331291 | PROCESS FOR THE PREPARATION OF DROSPIRENONE - A process is described for the preparation of drospirenone, a synthetic steroid with progestogenic, antimineralocorticoid and antiandrogenic activity, useful for preparing pharmaceutical compositions with contraceptive action by the oxidation of 17α-(3-hydroxypropyl)-6β,7β,15β, 16β-dimethylene-5β-androstane-3β,5,17β-triol. | 12-30-2010 |
20120264723 | PROCESS FOR THE PREPARATION OF DROSPIRENONE - A process is described for the preparation of drospirenone, a synthetic steroid with progestogenic, antimineralocorticoid and antiandrogenic activity, useful for preparing pharmaceutical compositions with contraceptive action; comprising the oxidation of 17α-(3-hydroxypropyl)-6β,7β,15β,16β-dimethylene-5β-androstane-3β,5,17β-triol. | 10-18-2012 |
Silvia Rachor, Golbach DE
Patent application number | Description | Published |
---|---|---|
20090022275 | Medical examination or intervention device - A medical examination or intervention device that includes at least one component, in particular a C-arm, that can be moved under a user's control via a manual control device, as well as a collision monitoring device embodied for ascertaining an imminent collision and/or one having already occurred, with the control device having a haptic indicating means, controlled by the collision monitoring device, for indicating an imminent component collision and/or one having already occurred. | 01-22-2009 |
Silvia Rachor, Goldbach DE
Patent application number | Description | Published |
---|---|---|
20080279333 | Angiography device and associated recording method with a mechanism for collision avoidance - The present invention involves an angiography device for examining vessels of patients having an x-ray emitter and an associated detector, having an image processing unit, an image display unit, a control unit, a collision computer and sensors. The sensors, which are fastened to the angiography device, are designed to scan the outer dimensions of the patient prior to the actual examination and during the examination. The data obtained in this way can be fed into a memory of the collision computer and the system is controllable by a software of the collision computer such that the movement of the system when the system and patient become too close can be automatically slowed down or completely stopped by means of a the control unit. | 11-13-2008 |
20090018701 | Medical diagnosis and/or intervention device - On a medical diagnosis and/or intervention device having a movable component, collision sensors are to be arranged without the cabling outlay becoming too high. This is made possible by the collision sensors being capable of sending signals wirelessly. The voltage supply can also be provided wirelessly along a section by using e.g. a slip ring. | 01-15-2009 |
20090124909 | Medical system and method for visualizing regions being monitored in a medical system - The invention relates to a medical diagnostic or therapy system comprising a system controller and at least one moving apparatus component, comprising a contour detecting unit which is constructed for detecting the position of components of the diagnostic or therapy system, and at least one projector that is decoupled from the contour detecting unit and is constructed for visualizing the region being monitored in which the component of the diagnostic and/or therapy system scanned by the contour detecting unit is arranged. The invention also relates to a method for visualizing regions being monitored in a medical diagnostic or therapy system of this kind. | 05-14-2009 |
Silvia Ragno, Cambridge GB
Patent application number | Description | Published |
---|---|---|
20100303867 | A COMPOSITION COMPRISING A NOTCH LIGAND AND AN ALLERGENB OR ALLERGEN BYSTANDER ANTIGEN - A method is provided for reducing an immune response to an allergen or antigenic determinant thereof in a mammal by administering a modulator of the Notch signalling pathway. | 12-02-2010 |
Silvia Revelli, Rosario AR
Patent application number | Description | Published |
---|---|---|
20110038887 | Novel Vaccine Against Trypanosoma Cruzi Infection - The present invention relates to a vaccine against | 02-17-2011 |
Silvia Rivara, Noceto IT
Patent application number | Description | Published |
---|---|---|
20100267836 | NOVEL MELATONIN LIGANDS HAVING ANTIDEPRESSANT ACTIVITY AS WELL AS SLEEP INDUCING PROPERTIES - Novel melatonin ligands of Formula I: | 10-21-2010 |
20150045442 | NOVEL MELATONIN LIGANDS HAVING ANTIDEPRESSANT ACTIVITY AS WELL AS SLEEP INDUCING PROPERTIES - Novel melatonin ligands of Formula I: | 02-12-2015 |
Silvia Sarafova, Port Orange, FL US
Patent application number | Description | Published |
---|---|---|
20100095452 | Method and Apparatus for Handling a Person - A lightweight, portable device allows a caregiver to fix one or two of the caregiver's lower legs and knees in position with respect to one or two of a patient's lower legs and knees so that the fixed lower legs together support and balance the combined body weight of the caregiver and patient, allowing the caregiver to pivot the patient up or down from a seated position by using the fixed knees as a fulcrum. The device has a central concavity that engages one person's leg below the knee from one direction, and peripheral concavities on either side of the central concavity that engage another person's legs below the knee from the opposite direction. Legs in the peripheral concavities partially straddle the leg in the central concavity. The device may be strapped onto the patient. | 04-22-2010 |
Silvia Sauf, Dusseldorf DE
Patent application number | Description | Published |
---|---|---|
20080305063 | 1-aza-3,7-dioxabicyclo[3.3.0]octane compounds and their use as pro-fragrances - 1-aza-3,7-dioxabicyclo[3.3.0]octane compounds, process for their preparation, their use as pro-fragrances, and washing and cleaning compositions, fabric softeners and cosmetics comprising them, and a process for prolonging the odor perception of such compositions. | 12-11-2008 |
20120004328 | LILIAN SURROGATE - Due to toxicological concerns, it may be desirable to replace the fragrance compound lilial with less problematic compounds without losing the creative power and quality regarding perfumes. The present invention addresses this need by using selected oxazolidines described herein. | 01-05-2012 |
Silvia Sauf, Duesseldorf DE
Patent application number | Description | Published |
---|---|---|
20090312231 | 1-Aza-3,7-Dioxabicyclo[3,3,0]Octane Compounds and Monocyclic Oxazolidines as Pro-Fragrances - Silicic acid esters to which fragrances are bound, preferably as 1-aza-3,7-dioxabicyclo[3,3,0]octane compounds or as monocyclic oxazolidines and that are suitable for adding fragrance to detergents and cleaning agents because they release the bound fragrances in hydrolysis. | 12-17-2009 |
20130017990 | LILIAL SURROGATE - Due to toxicological concerns, it may be desirable to replace the fragrance compound lilial with less problematic compounds without losing the creative power and quality regarding perfumes. The present invention addresses this need by using selected oxazolidines such as silvialoxazolidine described herein in conjunction with 1 or more additional scent components selected from a group of compounds such as methoxymelonal. | 01-17-2013 |
Silvia Schievano US
Patent application number | Description | Published |
---|---|---|
20100179641 | MULTI-LAYERED STENTS AND METHODS OF IMPLANTING - A method of percutaneously delivering a multi-layered stent assembly to a desired implantation location of a patient including the steps of radially compressing a multi-layered stent assembly to a compressed size for implantation in a patient, the multi-layered stent assembly including a first stent, a second stent coaxially positioned within at least a portion of a length of the first stent, and a valve, wherein the first stent comprises at least one different material property than the second stent. The method further includes delivering the multi-layered stent assembly to the desired implantation location of the patient using a delivery system and substantially simultaneously expanding the first stent and the second stent of the multi-layered stent assembly at the desired implantation location to a radially expanded size that is larger than the compressed size. | 07-15-2010 |
Silvia Schievano, London GB
Patent application number | Description | Published |
---|---|---|
20080262593 | Multi-layered stents and methods of implanting - A method of percutaneously delivering a multi-layered stent assembly to a desired implantation location of a patient including the steps of radially compressing a multi-layered stent assembly to a compressed size for implantation in a patient, the multi-layered stent assembly including a first stent, a second stent coaxially positioned within at least a portion of a length of the first stent, and a valve, wherein the first stent comprises at least one different material property than the second stent. The method further includes delivering the multi-layered stent assembly to the desired implantation location of the patient using a delivery system and substantially simultaneously expanding the first stent and the second stent of the multi-layered stent assembly at the desired implantation location to a radially expanded size that is larger than the compressed size. | 10-23-2008 |
20150066134 | MULTI-LAYERED STENTS AND METHODS OF IMPLANTING - A method of percutaneously delivering a multi-layered stent assembly to a desired implantation location of a patient including the steps of radially compressing a multi-layered stent assembly to a compressed size for implantation in a patient, the multi-layered stent assembly including a first stent, a second stent coaxially positioned within at least a portion of a length of the first stent, and a valve, wherein the first stent comprises at least one different material property than the second stent. The method further includes delivering the multi-layered stent assembly to the desired implantation location of the patient using a delivery system and substantially simultaneously expanding the first stent and the second stent of the multi-layered stent assembly at the desired implantation location to a radially expanded size that is larger than the compressed size. | 03-05-2015 |
Silvia Schuss, Feldkirchen DE
Patent application number | Description | Published |
---|---|---|
20100288707 | METHOD FOR CONDITIONING A WASTE SOLUTION CONTAINING ORGANIC SUBSTANCES AND METALS IN IONIC FORM, OBTAINED DURING WET-CHEMICAL CLEANING OF CONVENTIONAL OR NUCLEAR PLANTS - A method is provided for conditioning a waste solution obtained during the wet-chemical cleaning of conventional or nuclear plants and containing organic substances and metals in ionic form. At least a portion of the organic substance is degraded by electrochemical treatment or UV radiation of the waste solution, at least one metal precipitates by the addition of phosphoric acid and a resultant phosphate precipitate is removed from the waste solution. | 11-18-2010 |
Silvia Solda, Padova IT
Patent application number | Description | Published |
---|---|---|
20100079190 | Power Transistor and Method for Controlling a Power Transistor - Embodiments of the invention are related to a power transistor and a method for controlling a power transistor. In one embodiment a power transistor comprises a power semiconductor body with a plurality of power transistor cells each having a control electrode and a current path. The power transistor furthermore comprises a temperature sensor formed by at least one transistor cell in the power semiconductor body whose control electrode is coupled to one electrode of the current path forming a reversed biased pn-junction. | 04-01-2010 |
Silvia Sorribes, Barcelona ES
Patent application number | Description | Published |
---|---|---|
20100221143 | FRAGRANCE DELIVERY SYSTEM - The invention provides a fragrance delivery system comprising: a control unit for controlling a release mechanism to release at least one selected fragrance, said control unit comprising a selection unit for selecting said selected fragrance from at least two fragrances and controlling said release mechanism to release said selected fragrance, and a switching element for switching said release mechanism between an first state and an second state or vice versa, in which first state said release mechanism releases said selected fragrance at a higher rate than in said second state. The invention further provides a kit of parts comprising said device and a at least two fragrance reservoirs filled with a fragrance chemical. In addition, the invention relates to the use of a control unit for controlling a release mechanism to release a selected one of at least two fragrances in a fragrance delivery system, which control unit comprises a selection unit for selecting said selected fragrance and controlling said release mechanism to release said selected fragrance, and a switching element for switching said release mechanism between an active state and an inactive state or vice versa, and to the use of the present fragrance delivery system to deliver a fragrance to a space which is at least periodically occupied by an individual. | 09-02-2010 |
20100272599 | FRAGRANCE DELIVERY SYSTEM - The invention provides a fragrance delivery system comprising: a release mechanism for releasing at least one fragrance, and a control unit for controlling said release mechanism, said control unit comprising a selection unit for selecting said fragrance from at least two fragrances in response to turning on said fragrance delivery system. The invention further provides a kit of parts comprising said device and a at least two fragrance containers filled with a fragrance substance. In addition, the invention relates to the use of a release mechanism for releasing at least one fragrance and a control unit for controlling a release mechanism, said control unit comprising a selection unit for selecting said fragrance from at least two fragrances in response to turning on said fragrance delivery system. | 10-28-2010 |
Silvia Spriano, Torino IT
Patent application number | Description | Published |
---|---|---|
20080262625 | Medical Prosthetic Devices Presenting Enhanced Biocompatibility and Wear Resistance, Based On Colbalt Alloys and Process for Their Preparation - Medical prosthetic devices and in particular femoral head and/or acetabular cup of articular prostheses, made out of a cobalt alloy are submitted to a surface modification in order to obtain the formation of a thin surface layer constituted by Co—Ta and or Co—Nb intermetallic compounds, with the aim of inducing to the prosthetic device enhanced characteristics of biocompatibility, low metal ion release, higher hardness and wear resistance. The process of surface modification is performed by a treatment of the alloy in a molten salt mixture containing a tantalum halide, without applying any electrical field. | 10-23-2008 |
Silvia Suarez Luque, Santiago De Compostela ES
Patent application number | Description | Published |
---|---|---|
20080317864 | Chitosan and Heparin Nanoparticles - The invention is aimed at nanoparticulate systems for the controlled release of heparin. It is specifically aimed at nanoparticulate systems comprising chitosan, heparin and optionally a polyoxyethylenated derivative, and which are ionically cross-linked, as well as being aimed at processes for obtaining them. | 12-25-2008 |
20090074824 | STABLE NANOCAPSULE SYSTEMS FOR THE ADMINISTRATION OF ACTIVE MOLECULES - The invention is aimed at nanocapsule systems characterized in that they have high stability during long periods of time. These systems are useful for the controlled release of pharmacologically or cosmetically active ingredients of highly lipophilic nature. The system comprises nanocapsules with an average size less than 1 μm dispersed in an aqueous medium, wherein the nanocapsules have a structure which comprises a lipophilic phase containing a phospholipid component and one or more saturated and/or unsaturated C | 03-19-2009 |
Silvia Svegliati Baroni, Ancona IT
Patent application number | Description | Published |
---|---|---|
20090221481 | STIMULATORY AUTO-ANTIBODIES TO THE PDGF RECEPTORS AS PATHOLOGY MARKER AND THERAPEUTIC TARGET - An in vitro method for detecting the presence in a body sample of auto-antibodies for the PDGF receptor suitable for the diagnosis and prognosis of autoimmune diseases, in particular the systemic sclero-is and related diagnostic kits. Use of an inhibitor of ROS and/or Ras-ERK1/2 for the preparation of a medicament for therapeutic treatment of autoimmune diseases or of treating the Graft-Versus-Host-Reaction (GVHR). Pharmaceutical composition comprising an effective amount of an inhibitor of ROS and/or Ras-ERK1/2, and proper diluents, and/or excipients, and/or adjuvants. | 09-03-2009 |
20120252037 | STIMULATORY AUTO-ANTIBODIES TO THE PDGF RECEPTOR AS PATHOLOGY MARKER AND THERAPEUTIC TARGET - An in vitro method for detecting the presence in a body sample of auto-antibodies for the PDGF receptor suitable for the diagnosis and prognosis of autoimmune diseases, in particular the systemic sclerosis and related diagnostic kits. Use of an inhibitor of ROS and/or Ras-ERK1/2 for the preparation of a medicament for therapeutic treatment of autoimmune diseases or of treating the Graft-Versus-Host-Reaction (GVHR). Pharmaceutical composition comprising an effective amount of an inhibitor of ROS and/or Ras-ERK1/2, and proper diluents, and/or excipients, and/or adjuvants. | 10-04-2012 |
Silvia Sztoj, Ludwigshafen DE
Patent application number | Description | Published |
---|---|---|
20100122379 | Active Ingredient Compositions for Plant Protection - The present invention relates to novel active substance compositions for plant protection in the form of finely divided active-substance-containing particles which compositions comprise | 05-13-2010 |
Silvia Tenenti, Rome IT
Patent application number | Description | Published |
---|---|---|
20080270597 | End user control configuration system with dynamic user interface - An end user control configuration (EUC) system with dynamic user interface provides a user friendly tool for consumers to self-provision and manage network services such as Voice over Internet Protocol (VoIP) services. The EUC system dynamically generates graphical user interface (GUI) renderings that assist users in the completion of tasks related to provisioning, and managing network services. The EUC system allows telecommunication service providers to effectively hide the complexity of operational support systems (OSS) and the network elements that deliver the network services. The EUC system solves the technical problems of reducing the cycle-time to self-provision network services, assisting users to complete the tasks required to activate, and manage network services, and actually activating and managing the network services. | 10-30-2008 |
20100218041 | END USER CONTROL CONFIGURATION SYSTEM WITH DYNAMIC USER INTERFACE - An end user control configuration (EUC) system with dynamic user interface provides a user friendly tool for consumers to self-provision and manage network services such as Voice over Internet Protocol (VoIP) services. The EUC system dynamically generates graphical user interface (GUI) renderings that assist users in the completion of tasks related to provisioning, and managing network services. The EUC system allows telecommunication service providers to effectively hide the complexity of operational support systems (OSS) and the network elements that deliver the network services. The EUC system solves the technical problems of reducing the cycle-time to self-provision network services, assisting users to complete the tasks required to activate, and manage network services, and actually activating and managing the network services. | 08-26-2010 |
20100265940 | IMS APPLICATION FOR MULTI-CHANNEL SERVICES - An Internet protocol multimedia subsystem (IMS) application executes services, such as (Internet Protocol) IP contact center services, accessible over different access channels. An IMS application server includes a service creation layer operable to provide components for creating a hosted service, testing the hosted service and deploying the hosted service into a service execution layer. The service execution layer includes service logic components operable to execute the hosted service, and communication components operable to connect to an external service involved in executing the hosted service. | 10-21-2010 |
Silvia Trasciatti, Ospedaletto IT
Patent application number | Description | Published |
---|---|---|
20090042833 | PHARMACEUTICAL FORMULATION FOR THE TREATMENT OF OSTEOARTHRITIS CONTAINING CLODRONIC ACID AND HYALURONIC ACID - Disclosed are pharmaceutical compositions containing clodronic acid and hyaluronic acid or their salts as active constituents, mixed with suitable vehicles. | 02-12-2009 |
Silvia Trasciatti, Pisano IT
Patent application number | Description | Published |
---|---|---|
20090312329 | Cyclic hydroxylamine as psychoactive compounds - A compound of formula (I): in which X represents O or CH | 12-17-2009 |
20120015947 | Cyclic hydroxylamine as psychoactive compounds - A compound of formula (I): | 01-19-2012 |
Silvia Vignolini, Vaiano IT
Patent application number | Description | Published |
---|---|---|
20090103884 | Method For Producing Rewritable Photonic Devices - Method for the creation of a rewritable photonic device inserted in a photonic crystal ( | 04-23-2009 |
Silvia Werner, Kahl DE
Patent application number | Description | Published |
---|---|---|
20090143588 | QUARTZ GLASS MICRO-PHOTOREACTOR AND SYNTHESIS OF 10-HYDROXYCAMPTOTHECIN AND 7-ALKYL 10-HYDROXYCAMPTOTHECIN - A process for the production of 10-hydroxycamptothecin | 06-04-2009 |
20140187727 | 1,2-CYCLOHEXANEDIAMINPLATINUM(II)-BIS-(4-METHYLBENZENESULFONATE) AND THE HYDRATES THEREOF - The present invention describes the dihydrate of 1,2-cyclohexanediaminplatinum(II)-bis-(4-methylbenzenesulfonate), a method for producing 1,2-cyclohexanediaminplatinum(II)-bis-(4-methylbenzenesulfonate) and the hydrates thereof, and the use of 1,2-cyclohexanediaminplatinum(II)-bis-(4-methylbenzenesulfonate) and of the hydrates thereof. | 07-03-2014 |